JG
ALNY icon

Jain Global’s Alnylam Pharmaceuticals ALNY Stock Holding History

Jain Global’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8M Buy
55,686
+7,724
+16% +$2.33M 0.07% 267
2026
Q1 		$15.9M Buy
+47,962
New +$16.3M 0.07% 259
2025
Q4 		– Sell
-78,046
Closed -$35.6M – 1203
2025
Q3 		$35.6M Buy
78,046
+61,316
+367% +$25M 0.17% 89
2025
Q2 		$5.46M Buy
16,730
+10,509
+169% +$2.91M 0.04% 320
2025
Q1 		$1.68M Buy
+6,221
New +$1.6M 0.02% 379

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jain Global's ALNY Position: Q2 2026 in Review

Jain Global increased its Alnylam Pharmaceuticals (ALNY) stake by 16% in Q2 2026, buying an estimated $2.33M and bringing the position to 55,686 shares worth $16.8M. The position accounts for 0.07% of the portfolio, ranked #267.

Jain Global first reported a position in ALNY in Q1 2025 and has held it in 5 quarters since. The position peaked at $35.6M in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Jain Global held 55,686 shares of Alnylam Pharmaceuticals worth $16.8M as of Q2 2026.
  • Jain Global bought 7,724 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $2.33M.
  • Alnylam Pharmaceuticals made up 0.07% of Jain Global's portfolio in Q2 2026, its #267 holding.
  • Jain Global first reported a position in Alnylam Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Jain Global's Alnylam Pharmaceuticals position peaked at $35.6M in Q3 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.